fructosamine has been researched along with deoxyglucose in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (26.32) | 18.2507 |
| 2000's | 5 (13.16) | 29.6817 |
| 2010's | 21 (55.26) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Emoto, M; Inoue, T; Morii, H; Nishizawa, Y; Tabata, T | 1 |
| Akanuma, Y; Baba, S; Kanazawa, Y; Kawai, T; Kawazu, S; Kuzuya, T; Ohta, M; Toyota, T; Yamanouchi, T; Yoshioka, S | 1 |
| Fujita, S; Katayama, Y; Matsuyama, T | 1 |
| Dewald, L; Kajita, M; Miyazaki, T; Niwa, T; Sone, J | 1 |
| Nagai, M; Sakata, K; Shirahama, S; Sueta, H; Tanaka, T; Yanagawa, H | 1 |
| Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T | 1 |
| Arisaka, T; Honda, N; Kawamori, R; Kinoshita, J; Kurahashi, Y; Mochizuki, K; Nakamura, M; Tohjima, T; Watanabe, K; Yamamoto, S; Yoshimoto, T | 1 |
| Hasegawa, T; Hasegawa, Y; Kurimoto, F; Takada, M; Tsuchiya, Y | 1 |
| Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K | 1 |
| Langborg, A; Minhas, HS; Thornalley, PJ | 1 |
| Akanuma, Y; Kawakami, M; Ohashi, Y; Saito, Y; Tanaka, A; Yamada, N | 1 |
| Izumi, K; Noda, M | 1 |
| Gotoh, M; Hirooka, Y; Iguchi, A; Li, C; Yatoh, M | 1 |
| Buse, JB; Button, EA; Dungan, KM; Kato, S; Kelly, MM; Largay, J; Wittlin, S | 1 |
| True, MW | 1 |
| Ballantyne, CM; Brancati, FL; Coresh, J; Hoogeveen, RC; Selvin, E; Steffes, MW | 1 |
| Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH | 1 |
| Beck, R; Kollman, C; Mauras, N; Ruedy, K; Steffes, M; Wilson, DM; Xing, D | 1 |
| Foo, JP; Mantzoros, CS | 1 |
| Cao, X; Huang, Z; Li, Y; Liu, J; Liu, L; Wan, X | 1 |
| Juraschek, SP; Miller, ER; Selvin, E; Steffes, MW | 1 |
| Dungan, KM | 1 |
| Juraschek, SP; Selvin, E; Steffes, MW | 1 |
| Chin, SO; Choi, MC; Chon, S; Fraterrigo, G; Kim, YS; Kwon, MK; Lee, YJ; Oh, S; Pozzilli, P; Rhee, SY; Woo, JT | 1 |
| Parrinello, CM; Selvin, E | 1 |
| Chan, CL; Kelsey, M; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Coresh, J; Couper, D; Eckfeldt, JH; Lutsey, PL; Parrinello, CM; Selvin, E; Steffes, MW | 1 |
| Bergenstal, RM; Coresh, J; Grams, ME; Maruthur, NM; Parrinello, CM; Selvin, E; Sharrett, AR | 1 |
| Lv, LY; Shi, DB; Zhou, Q | 1 |
| Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Morales, FJ; Navarro, M | 1 |
| He, X; Sacks, DB; Saenger, AK; Selvin, E; Warren, B | 1 |
| Mendes, N; Serrano, F; Tavares Ribeiro, R | 1 |
| Ballantyne, CM; Ballew, SH; Coresh, J; Ding, N; Folsom, AR; Heiss, G; Hirsch, AT; Hoogeveen, RC; Jaar, B; Kwak, L; Matsushita, K; Salameh, M; Selvin, E; Sharrett, AR | 1 |
| Colodner, R; Hasanein, J; Hissin, N; Mirsky, N; Nachum, Z; Shwartz, N; Twafra, S; Yefet, E | 1 |
| Brinton, JT; Chan, CL; Nadeau, KJ; Tommerdahl, KL; Vigers, T; Zeitler, PS | 1 |
| Brennan, L; Dussort, P; Feskens, E; Flourakis, M; Lindner, LME; Mela, D; Rabbani, N; Rathmann, W; Respondek, F; Stehouwer, C; Theis, S; Thornalley, P; Vinoy, S | 1 |
| Hostiuc, M; Hostiuc, S; Negoi, I | 1 |
7 review(s) available for fructosamine and deoxyglucose
| Article | Year |
|---|---|
[Recent progress in evaluation of glycemic control by glycated protein and 1,5-AG].
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hexosamines; Humans; Serum Albumin | 1995 |
[Laboratory markers for glycemia and their target].
Topics: Biomarkers; Blood Glucose; Clinical Trials as Topic; Deoxyglucose; Diabetes Mellitus; Evidence-Based Medicine; Fructosamine; Glucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Ketones; Serum Albumin; Urea | 2002 |
Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Humans; Precision Medicine | 2009 |
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Prognosis; Prospective Studies; Serum Albumin | 2014 |
Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Maternal Serum Screening Tests; Pregnancy; Serum Albumin | 2018 |
Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Humans | 2020 |
Markers of hyperglycemia in the vitreous humor. A systematic review and meta-analysis.
Topics: 3-Hydroxybutyric Acid; Biomarkers; Deoxyglucose; Forensic Medicine; Fructosamine; Glucose; Humans; Hyperglycemia; Lactic Acid; Postmortem Changes; Vitreous Body | 2021 |
4 trial(s) available for fructosamine and deoxyglucose
| Article | Year |
|---|---|
Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Hexosamines; Humans; Reference Values | 1991 |
A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2001 |
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration | 2011 |
Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Topics: Adolescent; Biomarkers; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Obesity; Prediabetic State; Serum Albumin | 2016 |
27 other study(ies) available for fructosamine and deoxyglucose
| Article | Year |
|---|---|
Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1992 |
Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Hexosamines; Humans; Inositol; Male; Mass Spectrometry; Middle Aged; Reference Values; Renal Dialysis; Uremia | 1994 |
[Efficacy of hemoglobin-Alc, fructosamine, and 1,5-anhydroglucitol in community screening for diabetes mellitus].
Topics: Adult; Aged; Aged, 80 and over; Community Health Services; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Mass Screening; Middle Aged | 1993 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides | 1996 |
Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Glucose; Blood Platelets; Body Mass Index; Cytosol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Characteristics | 1998 |
Insulin-like growth factors - insulin-like growth factor binding protein axis and diabetic control in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Humans; Insulin-Like Growth Factor Binding Proteins; Male; Somatomedins | 1998 |
Economic evaluation of alternative indicators for screening for diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1999 |
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
Topics: Deoxyglucose; Fructosamine; Glucose; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; In Vitro Techniques; Lysine; Proteins; Pyruvaldehyde; Schiff Bases; Serum Albumin | 1999 |
Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Sex Characteristics; Uric Acid | 2005 |
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Monitoring, Ambulatory; Monitoring, Physiologic; Postprandial Period; Reproducibility of Results | 2006 |
Racial differences in glycemic markers: a cross-sectional analysis of community-based data.
Topics: Aged; Black People; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Erythrocytes; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; White People | 2011 |
The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Topics: Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; Child; Child, Preschool; Deoxyglucose; Diabetes Mellitus, Type 1; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Serum Albumin | 2011 |
The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
Topics: Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Predictive Value of Tests; Serum Albumin | 2011 |
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Remission Induction; Time Factors | 2012 |
Alternative markers of hyperglycemia and risk of diabetes.
Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Proportional Hazards Models; Risk Factors; Serum Albumin | 2012 |
Predicting outcomes and assessing control with alternate glycemic markers.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male | 2012 |
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Deoxyglucose; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Hyperglycemia; Hypertension; Male; Renal Insufficiency, Chronic; Serum Albumin; Sex Factors | 2012 |
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Predictive Value of Tests; Republic of Korea | 2013 |
Total Short-term Variability in Biomarkers of Hyperglycemia in Older Adults.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Cohort Studies; Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin | 2015 |
Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Racial Groups; Risk Factors; Serum Albumin | 2016 |
The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.
Topics: Adult; Aged; Asian People; Biomarkers; Blood Chemical Analysis; Blood Glucose; Deoxyglucose; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Reference Values; Serum Albumin; Young Adult | 2017 |
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin | 2017 |
Evaluation of an olive leaf extract as a natural source of antiglycative compounds.
Topics: Chromatography, Liquid; Deoxyglucose; Fructosamine; Galactose; Glycation End Products, Advanced; Glycosylation; Glyoxal; Lysine; Olea; Ornithine; Phenols; Phenylethyl Alcohol; Plant Extracts; Plant Leaves; Pyrimidines; Pyruvaldehyde; Tandem Mass Spectrometry | 2017 |
Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
Topics: Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Reference Standards; Serum Albumin | 2018 |
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Topics: Biomarkers; Blood Glucose; Critical Illness; Deoxyglucose; Diabetes Mellitus; Diabetic Foot; Disease Progression; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Incidence; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Severity of Illness Index; Time Factors; United States | 2018 |
Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Risk Factors | 2019 |
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Topics: Adolescent; Child; Cystic Fibrosis; Deoxyglucose; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Prediabetic State; Serum Albumin | 2019 |